We’ve all been there. Someone sent you something but you missed it. It wasn’t sent via your preferred channel. You have been inundated with emails, messages on Teams, WhatsApp, iMessage, etc… the list goes on. And you simply didn’t see it through the mass of communication we receive daily. It’s a common challenge that marketers face – how do you get your message in front of the right people at the right time, and most importantly, make sure they read it?
Relevance. If your message is not relevant to the recipient, why would it stand out? A recent article in Pharmaphorum talks about the digital deluge of content HCPs receive. The shift change to digital engagement has been swift but with it, a tendency to just push content out without considering its relevance to the recipient.
Effective HCP engagement is essential for pharma. Communicating digital peer-reviewed scientific articles (ePrints) from leading medical publishers – in line with HCP needs and interests ensures relevance and drives communication effectiveness as demonstrated by research by Across Health, CMI Media Group, Clarivate and many others.
Tangent90 develop solutions that address the challenges in distributing ePrints such as copyright protection, adherence to terms and conditions and tracking, enabling pharma to share digital copyright content directly with HCPs, through their existing channels as well as third-party channels. We have built up our experience with pharma over many years. As a leading SaaS company, we work with 15 out of the top 25 global pharma companies. Our credentials are further evidenced by our Veeva Silver Certified Technology Partners status – one of the first-ever partners to achieve Silver status and of course the publishing industry partnerships.
To find out more about how Tangent90 can support you in managing your scientific content distribution, please contact us at hello@tangent90.com.
